Integrative analysis of genomic and epigenetic regulation of endometrial cancer
Open Access
- 15 May 2020
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 12 (10), 9260-9274
- https://doi.org/10.18632/aging.103202
Abstract
Endometrial carcinomas (EC) are characterized by high DNA copy numbers and DNA methylation aberrations. In this study, we sought to comprehensively explore the effect of these two factors on development and progression of EC by analyzing integrated genomic and epigenetic analysis to. We found high DNA copy number and DNA methylation abnormalities in EC, with 6308 copy-number variation genes (CNV-G) and 4376 methylation genes (MET-G). We used these CNV-G and MET-G to subcategorize the samples for prognostic analysis, and identified three molecular subtypes (iC1, iC2, iC3). Moreover, the subtypes exhibited different tumor immune microenvironment characteristics. A further analysis of their molecular characteristics revealed three potential prognostic markers (KIAA1324, nonexpresser of pathogenesis-related genes1 (NPR1) and idiopathic hypogonadotropic hypogonadism (IHH)). Notably, all three markers showed distinct CNV, DNA methylation, and gene expression profiles. Analysis of mutations among the three subtypes revealed that iC2 had fewer mutations than the other subtypes. Conversely, iC2 showed significantly higher CNV levels than other subtypes. This comprehensive analysis of genomic and epigenetic profiles identified three prognostic markers, therefore, provides new insights into the multi-layered pathology of EC. These can be utilized for accurate treatment of EC patients.Keywords
This publication has 23 references indexed in Scilit:
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Rare germline copy number deletions of likely functional importance are implicated in endometrial cancer predispositionHuman Genetics, 2014
- SHARP1 Suppresses Angiogenesis of Endometrial Cancer by Decreasing Hypoxia-Inducible Factor-1α LevelPLOS ONE, 2014
- Immunofluorescence-Detected Infiltration of CD4+FOXP3+ Regulatory T Cells is Relevant to the Prognosis of Patients With Endometrial CancerInternational Journal of Gynecologic Cancer, 2011
- GSTM1 and GSTT1 Copy Number Variation in Population-based Studies of Endometrial Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2011
- The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stressCell Death & Disease, 2010
- Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinomaLaboratory Investigation, 2008
- Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesisInternational Journal of Cancer, 2008
- DNA methylation analysis: a powerful new tool for lung cancer diagnosisOncogene, 2002